Gosegyne (Progesterone)

Gosegyne is used in hormone therapy where progesterone supplementation is clinically indicated. Its oral formulation allows systemic delivery of progesterone for various therapeutic purposes.

• Management of luteal phase deficiency in assisted reproductive cycles.
• Support of the luteal phase in natural menstrual cycles.
• Adjunct therapy in hormone replacement regimens for menopausal women.
• Treatment of certain menstrual disorders associated with low progesterone levels.
• Part of a combined regimen for prevention of endometrial hyperplasia in women receiving estrogen therapy.

Side effects reported with oral progesterone products such as Gosegyne vary in frequency and severity.

Common

• Mild nausea or gastrointestinal discomfort.
• Headache or dizziness.
• Breast tenderness or swelling.

Serious

• Signs of allergic reaction such as rash, itching, or swelling of the face.
• Unexplained vaginal bleeding.
• Symptoms of thromboembolic events, including leg pain or swelling and shortness of breath.

When considering Gosegyne, clinicians evaluate several precautionary factors to ensure safe use.

• Assess personal and family history of thromboembolic disease before initiating therapy.
• Review liver function, as progesterone metabolism occurs hepatically.
• Evaluate for known hypersensitivity to progesterone or excipients.
• Consider potential effects on mood or depressive symptoms, especially in patients with a history of mood disorders.
• Use caution in patients with uncontrolled hypertension or cardiovascular disease.
• Discuss pregnancy intentions, since progesterone supplementation may affect fetal development.

Gosegyne may interact with other medications, influencing its efficacy or safety profile.

Avoid

• Concurrent use with potent CYP3A4 inducers (e.g., rifampin, carbamazepine) that may reduce progesterone levels.
• Combination with anticoagulants that increase bleeding risk when hormonal effects alter coagulation.

Use with caution

• Co‑administration with other hormonal agents (e.g., estrogen, progestin) may require dose adjustments.
• Use alongside medications that affect hepatic metabolism (e.g., certain antifungals) may alter progesterone concentrations.
• Patients taking sedatives should be monitored for additive central nervous system effects.